UVRAG in autophagy, inflammation, and cancer

Autophagy. 2020 Feb;16(2):387-388. doi: 10.1080/15548627.2019.1709768. Epub 2020 Jan 7.

Abstract

Macroautophagy/autophagy deregulation has been observed in perpetuated inflammation and the proliferation of tumor cells. However, the mechanisms underlying these changes have yet to be well-identified. UVRAG is one of the key players of autophagy, but its role in vivo remained puzzling. Our recent study utilized a mouse model with inducible expression of a cancer-derived frameshift (FS) mutation in UVRAG that dominant-negatively inhibits wild-type UVRAG, resulting in impaired stimulus-induced autophagy. The systemically compromised autophagy, particularly mitophagy, notably increases inflammation and associated pathologies. Furthermore, our discovery indicates that time-dependent autophagy suppression and ensuing CTNNB1/β-catenin activation may serve as one tumor-promoting mechanism underpinning age-related cancer susceptibility.

Keywords: Autophagy; UVRAG; centrosome; inflammation; tumorigenesis; β-catenin.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Autophagosomes / metabolism
  • Autophagy*
  • Frameshift Mutation / genetics
  • Inflammation / metabolism*
  • Inflammation / pathology*
  • Mice
  • Neoplasms / metabolism*
  • Neoplasms / pathology*
  • Signal Transduction
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / metabolism*

Substances

  • Tumor Suppressor Proteins
  • UVRAG protein, mouse